Related Experiment Video

Updated: May 12, 2026

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

Aberrant miRNA expression in brain tumors: a subject attracting an increasing amount of attention

C David James

    Neuro-Oncology
    |March 27, 2013
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Zebrafish Model of Neuroblastoma Metastasis
    05:20

    Zebrafish Model of Neuroblastoma Metastasis

    Published on: March 14, 2021

    Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
    09:48

    Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

    Published on: August 23, 2024

    Related Experiment Videos

    Last Updated: May 12, 2026

    Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
    09:40

    Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

    Published on: October 4, 2019

    Zebrafish Model of Neuroblastoma Metastasis
    05:20

    Zebrafish Model of Neuroblastoma Metastasis

    Published on: March 14, 2021

    Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
    09:48

    Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

    Published on: August 23, 2024

    Related Concept Videos

    Abnormal Proliferation02:23

    Abnormal Proliferation

    Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
    MicroRNAs01:22

    MicroRNAs

    MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

    Articles linked to this work by shared authors, journal, and citation graph.

    Phase I Evaluation of Patients with Newly Diagnosed Glioblastoma Treated with Radiation, Nivolumab, and IDO1 Enzyme Inhibitor BMS-986205.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    LMNA-PRKDC axis enhances DNA repair and promotes chemoresistance in glioblastoma.

    Cell death & disease·2025

    Newly diagnosed glioblastoma IDHwt patients treated with radiation, nivolumab, and BMS-986205.

    Research square·2025

    The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurrent post-temozolomide mismatch repair-deficient glioblastoma.

    Neuro-oncology·2024

    ARF4-mediated retrograde trafficking as a driver of chemoresistance in glioblastoma.

    Neuro-oncology·2024

    Metixene is an incomplete autophagy inducer in preclinical models of metastatic cancer and brain metastases.

    The Journal of clinical investigation·2023

    H3K27me3 loss and METTL3-m6A converge to upregulate SOX11/SMARCA4 and drive H3K27-altered spinal cord glioma stemness and proliferation.

    Neuro-oncology·2026

    SNP rs2853669 potentially elevates the risk of glioblastoma development and leads to worse prognosis when in cis with mutant TERT promoter in a Japanese cohort.

    Neuro-oncology·2026

    Stem cell morphology defines functional heterogeneity and therapeutic vulnerabilities in glioblastoma.

    Neuro-oncology·2026

    Association of high tumor mutational burden with brain metastases: Insights from a large-scale database analysis.

    Neuro-oncology·2026

    Cancer Neuroscience: Establishing a home in Neuro-Oncology.

    Neuro-oncology·2026

    Glioma and ependymoma through the lens of brain development, stem cells, and plasticity.

    Neuro-oncology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us